Literature DB >> 8163974

Acetabular defect classification and surgical reconstruction in revision arthroplasty. A 6-year follow-up evaluation.

W G Paprosky1, P G Perona, J M Lawrence.   

Abstract

From 1982 to 1988, 147 cemented acetabular components were revised with cementless hemispheric press-fit components, with an average follow-up period of 5.7 years (range, 3-9 years). Acetabular defects were typed from 1 to 3 and reconstructed with a bulk or support allograft. Type 1 defects had bone lysis around cement anchor sites and required particulate graft. Type 2A and B defects displayed progressive bone loss superiorly and required particulate graft, femoral head bulk graft, or cup superiorization. Type 2C defects required medial wall repair with wafer femoral head graft. Type 3A and B defects demonstrated progressive amounts of superior rim deficiencies and were treated with structural distal femur or proximal tibia allograft. Six of the 147 components (4.0%), all type 3B, were considered radiographically and clinically unstable, warranting revision. Three of the six were revised. Moderate lateral allograft resorption was noted on radiographs, but host-graft union was confirmed at revision. Size, orientation, and method of fixation of the allografts play an important role in the integrity of structural allografts, while adequate remaining host-bone must be present to ensure bone ingrowth.

Entities:  

Mesh:

Year:  1994        PMID: 8163974     DOI: 10.1016/0883-5403(94)90135-x

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  233 in total

1.  Hip painful prosthesis: surgical view.

Authors:  Antonio Spinarelli; Vittorio Patella; Vito Conserva; Giovanni Vicenti; Vito Pesce; Silvio Patella
Journal:  Clin Cases Miner Bone Metab       Date:  2011-05

2.  The survival and fate of acetabular reconstruction with impaction grafting for large defects.

Authors:  Eduardo Garcia-Cimbrelo; Ana Cruz-Pardos; Eduardo Garcia-Rey; José Ortega-Chamarro
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

3.  [Mega cups and partial pelvic replacement].

Authors:  R von Eisenhart-Rothe; H Gollwitzer; A Toepfer; H Pilge; B M Holzapfel; H Rechl; R Gradinger
Journal:  Orthopade       Date:  2010-10       Impact factor: 1.087

4.  Long-term results for minor column allografts in revision hip arthroplasty.

Authors:  Paul T H Lee; Guy Raz; Oleg A Safir; David J Backstein; Allan E Gross
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

5.  Revision hip arthroplasty using impacted cancellous bone and cement: a long-term follow-up study.

Authors:  Gowthaman Arumugam; Shashi Kumar Nanjayan; Conal Quah; Philip Wraighte; Peter Howard
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-09-23

6.  CORR Insights(®): Custom Acetabular Cages Offer Stable Fixation and Improved Hip Scores for Revision THA With Severe Bone Defects.

Authors:  Thomas Jefferson Blumenfeld
Journal:  Clin Orthop Relat Res       Date:  2015-12-16       Impact factor: 4.176

7.  Total hip arthroplasty using a Kerboull-type plate for rapidly destructive coxarthrosis: comparison with uncemented acetabular component.

Authors:  Tomonori Baba; Yasuhiro Homma; Hidenori Ochi; Yu Ozaki; Mikio Matsumoto; Katsuo Shitoto; Kazuo Kaneko
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-01-11

8.  [Treatment of acetabular defects with the trabecular metal revision system].

Authors:  G I Wassilew; V Janz; C Perka; M Müller
Journal:  Orthopade       Date:  2017-02       Impact factor: 1.087

9.  Acetabular revisions using a cementless oblong cup: five to ten year results.

Authors:  R Civinini; A Capone; C Carulli; M Villano; M I Gusso
Journal:  Int Orthop       Date:  2007-01-13       Impact factor: 3.075

10.  [Bone defect adjusted strategy in revision arthroplasty of the hip : Wich implant in wich situation? Innovations and approved methods].

Authors:  B S Craiovan; J Grifka; A Keshmiri; B Moser; M Wörner; T Renkawitz
Journal:  Orthopade       Date:  2015-05       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.